Moleculin Biotech Inc. – Filings and Transcripts

NASDAQ: MBRX
Share price (8/5/26): $0.39
Market cap (8/5/26): $7.596 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Initial registration of new securities – amended

Initial registration of new securities – amended

Initial registration of new securities

Draft registration statement

Ownership Filter

Intracoastal Capital, LLC

Foster Jonathan P.

Picker Donald H

Picker Donald H

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

MIRACLE R/R AML Trial Reports Positive Interim Data With 37% Blinded CRc in Venetoclax-Failed Patients

Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-Fold Greater Than Control

Material Disclosure, Financial Statements or Exhibits

Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary revised proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness